Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.7 |
mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.01 | 0.7 |
mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.098 | 0.7 |